TuHURA Biosciences Inc.
HURA | NASDAQ
$2.13
-$0.05 (-2.29%)
Sep 22, 2026, 10:46 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Jun 29, 2021 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 55K | 60K | 60K | 32K |
Gross Profit | n/a | n/a | -55K | -60K | -60K | -32K |
Operating Income | -31.8M | -17.65M | -8.45M | -14.8M | -22.68M | -21.57M |
Interest Income | 136.23K | 361.63K | 89.67K | 57.35K | n/a | n/a |
Pretax Income | -30.06M | -21.68M | -8.32M | -14.65M | -22.66M | -38.3M |
Net Income | -30.06M | -21.68M | -8.32M | -14.65M | -22.66M | -38.3M |
Selling & General & Admin | 7.58M | 3.87M | 5.73M | 5.43M | 7.45M | 9.73M |
Research & Development | 20.53M | 13.34M | 2.66M | 9.31M | 15.17M | 11.82M |
Other Expenses | 3.68M | 440.34K | n/a | n/a | n/a | n/a |
Operating Expenses | 31.8M | 17.65M | 8.4M | 14.74M | 22.62M | 21.54M |
Interest Expense | 625.28K | 4.14M | 18.69K | n/a | 629.29K | 120K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 31.8M | 17.65M | 8.45M | 14.8M | 22.68M | 21.57M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 47.93M | 18.66M | 752.91K | 46.29K | 27.83K | 14.79K |
Shares Outstanding (Diluted) | 47.93M | 18.66M | 752.91K | 46.29K | 27.83K | 14.79K |
EPS (Basic) | -0.63 | -1.21 | -11.29 | -324.48 | -903.03 | -2.81K |
EPS (Diluted) | -0.63 | -1.21 | -11.29 | -324.48 | -903.03 | -2.81K |
EBITDA | -29.36M | -17.43M | -8.27M | -14.59M | -21.97M | -38.15M |
EBIT | -29.43M | -17.54M | -8.32M | -14.65M | -22.03M | -38.18M |
Depreciation & Amortization | 71.27K | 116.71K | 55K | 60K | 60K | 32K |
Add to Watchlist
Select watchlists to add or remove HURA